Pagani A - Search Results

1

Levels and molecular properties of secretoneurin-immunoreactivity in the serum and urine of control and neuroendocrine tumor patients.

Ischia R, Gasser RW, Fischer-Colbrie R, Eder U, Pagani A, Cubeddu LX, Lovisetti-Scamihorn P, Finkenstedt G, Laslop A, Winkler H. Ischia R, et al. Among authors: pagani a. J Clin Endocrinol Metab. 2000 Jan;85(1):355-60. doi: 10.1210/jcem.85.1.6314. J Clin Endocrinol Metab. 2000. PMID: 10634410 Clinical Trial.

2

Neural and mesenchymal differentiations in Ewing's sarcoma cell lines. Morphological, immunophenotypic, molecular biological and cytogenetic evidence.

Pagani A, Fischer-Colbrie R, Eder U, Pellin A, Llombart-Bosch A, Bussolati G. Pagani A, et al. Int J Cancer. 1995 Nov 27;63(5):738-43. doi: 10.1002/ijc.2910630522. Int J Cancer. 1995. PMID: 7591294

3

Chromogranin A and B gene expression in carcinomas of the breast. Correlation of immunocytochemical, immunoblot, and hybridization analyses.

Pagani A, Papotti M, Höfler H, Weiler R, Winkler H, Bussolati G. Pagani A, et al. Am J Pathol. 1990 Feb;136(2):319-27. Am J Pathol. 1990. PMID: 2305832 Free PMC article.

4

Secretogranin II expression in Ewing's sarcomas and primitive neuroectodermal tumors.

Pagani A, Fischer-Colbrie R, Sanfilippo B, Winkler H, Cerrato M, Bussolati G. Pagani A, et al. Diagn Mol Pathol. 1992 Sep;1(3):165-72. Diagn Mol Pathol. 1992. PMID: 1342962

5

Expression of members of the chromogranin family in primary neuroblastomas.

Pagani A, Forni M, Tonini GP, Papotti M, Bussolati G. Pagani A, et al. Diagn Mol Pathol. 1992 Mar;1(1):16-24. doi: 10.1097/00019606-199203000-00003. Diagn Mol Pathol. 1992. PMID: 1342949

6

Nonspecific in situ hybridization reaction in neuroendocrine cells and tumors of the gastrointestinal tract using oligonucleotide probes.

Pagani A, Cerrato M, Bussolati G. Pagani A, et al. Diagn Mol Pathol. 1993 Jun;2(2):125-30. Diagn Mol Pathol. 1993. PMID: 8269277

7

Neuroendocrine differentiation in Ewing's sarcomas and primitive neuroectodermal tumors revealed by reverse transcriptase-polymerase chain reaction of chromogranin mRNA.

Pagani A, Macrí L, Rosolen A, Toffolatti L, Stella A, Bussolati G. Pagani A, et al. Diagn Mol Pathol. 1998 Feb;7(1):36-43. doi: 10.1097/00019606-199802000-00007. Diagn Mol Pathol. 1998. PMID: 9646033

8

Detection procedures for neuroblastoma cells metastatic to blood and bone marrow: blinded comparison of chromogranin A heminested reverse transcription polymerase chain reaction to tyrosine hydroxylase nested reverse transcription polymerase chain reaction and to anti-GD2 immunocytology.

Pagani A, Macri L, Faulkner LB, Tintori V, Paoli A, Garaventa A, Bussolati G. Pagani A, et al. Diagn Mol Pathol. 2002 Jun;11(2):98-106. doi: 10.1097/00019606-200206000-00006. Diagn Mol Pathol. 2002. PMID: 12045713

9

Expression of the gastrin-releasing peptide gene in carcinomas of the breast.

Pagani A, Papotti M, Sanfilippo B, Bussolati G. Pagani A, et al. Int J Cancer. 1991 Feb 1;47(3):371-5. doi: 10.1002/ijc.2910470310. Int J Cancer. 1991. PMID: 1847122

10

PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast.

Pagani A, Sapino A, Eusebi V, Bergnolo P, Bussolati G. Pagani A, et al. Virchows Arch. 1994;425(5):459-65. doi: 10.1007/BF00197548. Virchows Arch. 1994. PMID: 7850069

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

299 results

Search Page

Filters